Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Related posts:
Fredericksburg Farms Recalls 10 Ounce Scented Candles with Glass Lids Due to Laceration Hazard
March 15, 2023Pool Drain Covers Recalled Due to the Violation of the Virginia Graeme Baker Pool and Spa Safety Act...
April 26, 2023Betsy & Lace Recalls Children’s Nightgowns Due to Violation of Federal Flammability Standard and Bur...
February 15, 2023Views: 304